Meag Munich Ergo’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$16.2M Sell
54,142
-6,783
-11% -$1.95M 0.46% 60
2025
Q1
$16.9M Sell
60,925
-27,242
-31% -$6.84M 0.5% 56
2024
Q4
$19.8M Sell
88,167
-19,665
-18% -$4.62M 0.63% 54
2024
Q3
$24.3M Sell
107,832
-58,119
-35% -$13.5M 0.76% 53
2024
Q2
$37.4M Buy
165,951
+112,082
+208% +$26M 1.24% 39
2024
Q1
$13.1M Buy
53,869
+7,646
+17% +$1.76M 0.47% 58
2023
Q4
$9.49M Buy
46,223
+2,544
+6% +$497K 0.36% 61
2023
Q3
$7.86M Sell
43,679
-132
-0.3% -$24.4K 0.34% 67
2023
Q2
$8.43M Sell
43,811
-3,656
-8% -$633K 0.37% 70
2023
Q1
$7.6M Buy
47,467
+30,027
+172% +$4.76M 0.36% 69
2022
Q4
$2.89M Buy
+17,440
New +$2.76M 0.16% 95
2021
Q4
Sell
-7,953
Closed -$950K 210
2021
Q3
$950K Buy
7,953
+3,714
+88% +$446K 0.17% 110
2021
Q2
$485K Sell
4,239
-154
-4% -$18.2K 0.05% 264
2021
Q1
$519K Buy
+4,393
New +$475K 0.05% 250
2020
Q4
Sell
-4,040
Closed -$392K 197
2020
Q3
$392K Sell
4,040
-4,062
-50% -$404K 0.07% 175
2020
Q2
$816K Sell
8,102
-2,400
-23% -$221K 0.15% 133
2020
Q1
$929K Buy
10,502
+3,291
+46% +$290K 0.22% 97
2019
Q4
$603K Sell
7,211
-14,067
-66% -$1.21M 0.06% 254
2019
Q3
$1.72M Buy
21,278
+15,205
+250% +$1.31M 0.09% 240
2019
Q2
$521K Hold
6,073
0.04% 393
2019
Q1
$473K Sell
6,073
-8,622
-59% -$693K 0.04% 411
2018
Q4
$1.08M Hold
14,695
0.13% 223
2018
Q3
$1.33M Buy
+14,695
New +$1.27M 0.08% 261
2018
Q2
Sell
-60,636
Closed -$5.14M 383
2018
Q1
$5.14M Buy
60,636
+52,871
+681% +$5.08M 0.21% 152
2017
Q4
$723K Buy
+7,765
New +$642K 0.03% 398
2017
Q3
Sell
-40,718
Closed -$3.89M 277
2017
Q2
$3.89M Sell
40,718
-36,185
-47% -$3.22M 0.17% 161
2017
Q1
$6.83M Buy
+76,903
New +$6.76M 0.27% 136
2016
Q1
Sell
-120,836
Closed -$12.7M 245
2015
Q4
$12.7M Buy
+120,836
New +$11.9M 0.64% 52
2013
Q3
Sell
-81,888
Closed -$4.59M 256
2013
Q2
$4.59M Buy
+81,888
New +$4.44M 0.35% 97

Other funds holding COR

Meag Munich Ergo's COR Position: Q2 2025 in Review

Meag Munich Ergo reduced its Cencora (COR) stake by 11% in Q2 2025, selling an estimated $1.95M and leaving 54,142 shares worth $16.2M. The position accounts for 0.46% of the portfolio, ranked #60.

Meag Munich Ergo first reported a position in COR in Q2 2013 and has held it in 29 quarters since. The position peaked at $37.4M in Q2 2024. 1,346 funds tracked by Wall St. Rank hold COR as of Q2 2025.

  • Meag Munich Ergo held 54,142 shares of Cencora worth $16.2M as of Q2 2025.
  • Meag Munich Ergo sold 6,783 Cencora shares in Q2 2025, an estimated $1.95M.
  • Cencora made up 0.46% of Meag Munich Ergo's portfolio in Q2 2025, its #60 holding.
  • Meag Munich Ergo first reported a position in Cencora in Q2 2013 and has held it in 29 quarters since.
  • Meag Munich Ergo's Cencora position peaked at $37.4M in Q2 2024.
  • 1,346 funds tracked by Wall St. Rank held Cencora as of Q2 2025.

Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.